Edition:
United Kingdom

Edge Therapeutics Inc (EDGE.OQ)

EDGE.OQ on NASDAQ Stock Exchange Global Select Market

0.46USD
11 Dec 2018
Change (% chg)

$-0.00 (-0.97%)
Prev Close
$0.47
Open
$0.47
Day's High
$0.51
Day's Low
$0.46
Volume
121,464
Avg. Vol
67,251
52-wk High
$17.76
52-wk Low
$0.45

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.136
Jun '18 0.00 -0.405
Mar '18 0.00 -0.673
FY 2017 Dec '17 0.00 -0.879
Sep '17 0.00 -0.366
Jun '17 0.00 -0.444
Mar '17 0.00 -0.420
FY 2016 Dec '16 0.00 -0.329
Sep '16 0.00 -0.372
Jun '16 0.00 -0.325
Mar '16 0.00 -0.318
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.37 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta -- 0.91 0.90
Price to Sales (TTM) -- 116.41 5.77
Price to Book (MRQ) 4.04 15.60 5.12
Price to Tangible Book (MRQ) 4.05 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 50.05 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 90.38 5.80
Sales - 5 Yr. Growth Rate -- 31.32 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -36.57 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago 24.85 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -- 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 9.43 5.42 3.11
LT Debt to Equity (MRQ) 20.32 33.58 11.47
Total Debt to Equity (MRQ) 23.99 35.41 15.63
Interest Coverage (TTM) -54.28 -152.90 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.20
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -506.72 11.83
Operating Margin (TTM) -- -728.64 4.90
Operating Margin - 5 Yr. Avg. -- -526.20 7.44
Pre-Tax Margin (TTM) -- -694.91 5.91
Pre-Tax Margin - 5 Yr. Avg. -- -531.06 7.89
Net Profit Margin (TTM) -- -696.69 2.16
Net Profit Margin - 5 Yr. Avg. -- -534.51 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 25,687,735 898,898,415
Net Income/Employee (TTM) -1,482,231 2,194,099 106,547,429
Receivable Turnover (TTM) -- 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.23 -1.11 11.50
Return on Assets - 5 Yr. Avg. -- 2.88 12.67
Return on Investment (TTM) -43.75 0.29 15.02
Return on Investment - 5 Yr. Avg. -- 1.84 16.45
Return on Equity (TTM) -48.11 0.94 16.60
Return on Equity - 5 Yr. Avg. -- 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 66.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Edge Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 5.24 1.61 57 57
13 Week 9.08 3.77 63 61
26 Week 24.30 14.85 71 81
52 Week 1.66 -13.84 52 47
YTD -11.60 -22.37 33 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 31.90%
# of Holders: 46
Total Shares Held: 9,993,831
3 Mo. Net Change: -946,218
# New Positions: 3
# Closed Positions: 12
# Increased Positions: 9
# Reduced Positions: 26
# Net Buyers: -17
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.